Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huzhen Tongfeng is a Traditional Chinese Medicine (TCM) preparation developed by Guangzhou Jinan Biomedical Research and Development Base for the treatment of acute gouty arthritis. Formulated as a capsule, it is specifically indicated for patients diagnosed with the "damp-heat accumulation syndrome" (湿热蕴结证) according to TCM principles. The drug has been evaluated in Phase III clinical trials in China (e.g., CTR20150783) to assess its efficacy and safety in alleviating joint pain, swelling, and inflammation during acute gout flares. As a botanical-based therapy, it likely contains multiple active herbal ingredients intended to clear heat, resolve dampness, and provide analgesic effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huzhen Tongfeng.